Gain Therapeutics Inc.
GANX | NASDAQ
$1.90
+$0.06 (+3.26%)
Sep 22, 2026, 2:12 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -5.28 | -2.43 | -1.91 | -2.11 | -3.96 | -37.33 |
PEG Ratio | 0.17 | 0.05 | -0.12 | -0.26 | -0.01 | 1.97 |
PS Ratio | n/a | n/a | 771.06 | 265.47 | 334.55 | 4.61K |
PB Ratio | 5.72 | 6.73 | 3.38 | 1.97 | 1.59 | 21.45 |
P/FCF Ratio | -5.75 | -2.62 | -2.25 | -2.51 | -4.43 | -40.79 |
P/OCF Ratio | -5.75 | -2.62 | -2.26 | -2.53 | -4.46 | -41.05 |
OCF/S Ratio | n/a | n/a | -34.19K | -10.49K | -7.49K | -11.22K |
Debt / Equity Ratio | 0.04 | 0.09 | 0.08 | 0.07 | 0.05 | 0.20 |
Quick Ratio | 6.63 | 2.97 | 3.59 | 5.11 | 14.78 | 4.25 |
Current Ratio | 6.63 | 2.97 | 3.59 | 5.11 | 14.78 | 4.25 |
Asset Turnover | n/a | n/a | 0 | 0.01 | 0 | 0 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -108.60% | -278.10% | -177.03% | -93.17% | -39.90% | -57.69% |
Return on Assets | -88.35% | -168.36% | -119.66% | -72.99% | -35.63% | -37.25% |
Return on Invested Capital | -95.04% | -239.88% | -158.86% | -87.52% | -37.62% | -45.57% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 100% | 100% | 100% | 100% |
Net Profit Margin | n/a | n/a | -40.35K% | -12.56K% | -8.42K% | -12.39K% |
Pretax Profit Margin | n/a | n/a | -40.21K% | -12.49K% | -8.42K% | -12.37K% |
Operating Profit Margin | n/a | n/a | -40.33K% | -12.69K% | -8.38K% | -12.05K% |
FCF Margin | n/a | n/a | -34.22K% | -10.57K% | -7.55K% | -11.29K% |
EBITDA Margin | n/a | n/a | -40.06K% | -12.44K% | -8.41K% | -12.01K% |
Add to Watchlist
Select watchlists to add or remove GANX